58
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Upper reference limit, analytical quality specifications and clinical use of haemoglobin A1C

, , , , , & show all
Pages 609-622 | Published online: 08 Jul 2009

  • The Expert Committee on the Diagnosis and Classification of Diabetes Mellitas. Report on the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183 97.
  • World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. WHO. Geneva 1999 (WHO/ NCD/NCS/99.21.
  • The Diabetes Control and Complications Trial Research Group. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
  • The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complication trial. Diabetes 1995: 44: 969-83.
  • UK Prospective Diabetes study (UKPDS) Group. Intensive blood glucose control with sulphonylurcas or insulin compared with convention treatment and risk of complications in patient with type 2 diabetes (UKPDS 33) Lancet 1998 352: 837-53.
  • Stratlon IM. Adler AL. Neil HAW, Matthews DR Manley SE. Cull CA. Hadden D. Turner RC Holman RR on behalf of the UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvaseular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000; 321: 405-12
  • Tanne JH. Diabetes: a growing problem in the United States. Br Med J 2001; 122: 194-5.
  • Khaw K-T. Wareham N. Labin R. Bingham S Oakes S. WeIch A. Day N. Glycated haemoglobin diabetes, and mortality in men in the Norfolk cohort of the European Prospective Investigatior of Cancer and Nutrition (EPIC-Norfolk). Br Med. J 2001; 322: 15-8.
  • Thomas A. Standardization of HbA1c measurement the issues. British diabetes association Diabetes Med 2000; 17: 2-4.
  • Kenny D. Fraser CG. HyItoft Petersen P. Kallner A. Consensus agreement. Scand J Clin Lab Invest 1999: 59: 585-6.
  • Jorgensen LGM. Stahl M. Brandslund I. Hyltof Petersen P. Borch-Johnsen K. de Fine Olivarius N the plasma glucose reference interval in a low-risk population. The impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus II. Scand J Clin Lab Invest 2001: 61: 181-90.
  • Stahl M. Jorgensen LGM, Hyltoft Petersen P Brandslund I. dc Fine Olivurius N. Borch-Johnser K. Optimization of preanalyeical conditions and analysis of plasma glucose. I Impact of the new WHO and ADA recommendations on diagnosis o: diabetes mellitus. Scand J Clin Lab Invest 2001 61: 169-80.
  • Gibb I. Parnham A. Foilfrede M. Lecock F. Multicenter evaluation of Tosoh glyeohaemo globin analyzer. Clin Chem 1999: 45: 1833-41.
  • Weykamp CW, Pender TJ, Muskiat FAJ, Slik W vau der. Evaluation of a reference material for glycated haemoglobin. Eur J Clin Chem Clin Biochce 1996: 34: 67-72.
  • Jeppsson JO, Jemtorp P, Sundkvist G, Englund H Nylund V. Measurement of haemoglobin Alc by a new liquid Chromatographic assay: methodology clinical utility and relation to glucose tolerance evaluation. Clin Chem 1986; 32: 1867-72.
  • Hyltoft-Petersen P. Stock D, Blaabjerg O Pedersen B, Birkemosc E, Thienpont L, Flenstec Lassen J, Kjeldsen J. Graphical interpretation of analytical data from comparison of a field method with a reference method by use of difference plots Clin Chem 1997: 43: 2039- 46.
  • Hylloft Petersen P, Lytken Larson M. Horder M Prerequisite for the maintenance of a certain state of health by biochemical monitoring. In: Harris EK, Yasaka T, editors. Maintaining a health state within the individual. North-Holland: Elsevier Science Publishers BV IFIP-IMIA 1987: p. 147-58.
  • Lytken Larsen M, Fraser CG, Hyltoft Petersen P. A comparison of analytical goals for haemoglobin Alc derived using different strategies. Ann Clin Biochem 1991; 28: 272-8
  • Solberg HE. Approved recommendation on the theory of reference values Part 5 Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987: 25: 645-56.
  • Altman DG. Practical statistics for medical research. London: Chapman & Hall 1997 (ISBN 0 412 27630 5).
  • Lassen JF, Brandslund I. Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical differcnce and probability of significant change in consecutive measurements. Clin Chem 1995; 41: 444-7.
  • Sandberg S, Thue G. Quality specifications derived from objective analyses based upon clinical needs. Scand J Clin Lab Invest 1999, 59: 531-4.
  • Gowans EMS, Hyltoft Petersen P. Blaabjerg O, Horder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988: 48: 757-64.
  • Sebastian-Gambaro MA, Liro-Hernandez FJ, Fuentes-Aroeriu X. Intra- and inter-individual biological variability data bank. Eur J Clin Chem Clin Biochem 1997; 35: 845-912
  • Ricos C, Alvurez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV. Minchinela J. Perich C. Simon M. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999; 59: 491-500. (http: www.westgard com/hiodatabasel.ht
  • Fuentes-Arderiu X, Acebes-Fricyro G, GavasoNavarro L, Castiñeiras-Lacambra MJ. Premetroiogical (pre-analytical) variation of some biochemical quantities. Clin Chem Lab Med 1999: 37: 987-9.
  • Fraser C. Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting general applicable quality goals solely based on biology. Ann Clin Biochem 1997: 34: 8-12.
  • Olivarius N de Fine. Andreasen AH. Five-year all cause mortality of 1323 newly diagnosed middle-aged and elderly diabetic patients Data from the population-based study, diabetes care in general practice. Denmark. J Diabetes and its Complications 1997: 11: 83-9.
  • Wild SH. Diabetes care needs evidence based interventions to reduce risk of vascular disease. Br Med J 2000;,320: 1554-5.
  • Ohkubo Y, Kishtkawa H, Araki E, Miyata T, lsami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes. Res Clin Pract 1995; 28 103-17.
  • MeCance DR, Hanson RL, Pettitt DJ, Bennett PH, Hadden DR, Knowler WC. Diagnosing diabetes mellitus--do we need new criteria? Diabetologia 1997; 411 247-55.
  • John WG, Bullock DG, Mackenzie F, Methods for analysis of glycated haemoglobins: what is being measured. Diabetes Med 1992: 9: 15-9.
  • Steffes MW. Glyeemic control: perhaps we can define it. but can we measure it. Clin Chem 1995; 41: 180-1.
  • Johnson R. Standardization of haemoglobin Alc. Clin Chem 1997; 43: 1944-51.
  • Mosca A, Paleari R, Made A, Ferrero C. Locatelli M, Ceriotti F. Commutability of control materials in glucohaemoglobin determinations. Clin Chem 1998: 44: 632-8.
  • Little RR. Recent progress in glucohaemoglobin (HbA1c) testing Diabetes. Care 2000; 23: 205-6.
  • Kilpatrick H, Rumley AG, Dominiczak MH, Small M. Glycated haemoglobin values: problems in assessing blood glucose control in diabetes mellitus. Br Med J 1999; 309; 983-6.
  • Roberts NB, Amara AB, Morris M. Green BN. Long-term evaluation of electrospray ionization mass spectrometric analysis of glycaled haemoglobin. Clin Chem 2001:47: 316-21.
  • Finke A, Kobold U, Hoelzel W. Weykamp C, Miedema K, Jeppsson J-O. Preparation of a candidate primary reference material for the international standardization of HbAIc determination. Clin Chem Lab Med 1998: 36: 299-308.
  • Marshall SM, Barth JH. Standardization of HbAIc measurements: a consensus statement. Ann Clin Biochem 2000; 37 45-6.
  • Garde AH, Hansen AM, Skovgaard LT, Christensen JM. Seasonal and biological variation of blood concentrations of tolal cholesterol, dehydroepiandrostrrone sulfate. haemoglobin Alc. IgA. prolactin. and free testosterone in healthy women. Clin Chem 2000; 46: 551-9.
  • Maguire GA, Edwards MO. Seasonal variation in glycated haemoglobin in diabetes. Ann Clin Biochem 2001; 38: 59-60.
  • Ferrie CD, Sharpe TC, Price DA, Surteen RAH. Seasonal variation of glycated haemoglobin. Arch Dis Child 1987; 62: 959-60.
  • Hinde FRJ, Standen PJ, Mann NP, Johnston DJ. Seasonal variation of haemoglobin A1 in children with insulin-dependent diabetes mellitus. Ear J Pediatr 1989; 148: 597-9.
  • Fraser C, Optimal analytical performance for POCT. eJICC, vol. 13(1). eJIFCC original articles. IFCC Professional. Scientific Exchange Program Reports Editorial.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.